Orthopedic and sports medicine technology company Ortho Regenerative Technologies appointed Pierre Laurin to its board of directors.
Three things to know:
1. New Ortho RTi CEO Claude LeDuc was also appointed to the company's board of directors.
2. Mr. Laurin has over 35 years of experience in the pharmaceutical and biotech industry. He served as president and CEO of Life Sciences — a company that he founded — and raised almost $1 billion in equity, debt financing and international funding.
3. He is also a board member of Innovon Pharmaceuticals, Innodem Neurosciences and Invhealth Capital.
"Both Pierre and Claude are well-known and seasoned industry veterans with a long track record of developing strategic biotherapeutic partnerships and successfully raising the capital required to develop world leading technologies," said Steve Saviuk executive chairman of the board of directors.